Comparison of Clinical Effects of Salmeterol/Fluticasone Propionate Combination Products Delivered via Metered-Dose Inhaler with Dry Powder Inhaler in Patients with Moderate Asthma
Not Applicable
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000009990
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Current smokers, those who had pulmonary diseases with non reversible airflow obstruction such as COPD or pulmonary fibrosis were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Respiratory resistance and reactance measured by Forced Oscillation Technique (Most Graph)
- Secondary Outcome Measures
Name Time Method FeNO Asthma Control Test score Side effect